Oxford University works on adapting vaccine to prevent mutations | NOW

Oxford scientists are working on adapting vaccine due to mutations
Scientists at the University of Oxford are working on new versions of the Oxford / AstraZeneca vaccine, which should protect against the mutated variants of the coronavirus that have emerged in the United Kingdom, South Africa and Brazil, the British newspaper reports The Telegraph.

The team behind the Oxford / AstraZeneca vaccine is exploring the feasibility of redeveloping the technology behind the vaccine, The Telegraph writes. The British-Swedish pharmaceutical company AstraZeneca referred to the University of Oxford for comment. A university spokesperson says it is being carefully investigated to what extent the new variants of the coronavirus are resistant to the vaccines and which processes are necessary for the rapid development of a modified corona vaccine.

British Prime Minister Boris Johnson said on Wednesday that the British drug regulator will be ready to review and approve a modified vaccine that is effective against the mutated variants of the coronavirus.


Leave a Reply

Your email address will not be published. Required fields are marked *